|
26
|
|
$23.2M
|
+$674K
|
+21,649
|
+3%
|
|
|
27
|
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
$22.8M
|
+$11.6M
|
+371,121
|
+93%
|
|
|
28
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$22.8M
|
+$24M
|
+771,158
|
New
|
|
|
29
|
MPM BioImpact
Boston,
Massachusetts
|
$21.1M
|
+$350K
|
+11,243
|
+2%
|
|
|
30
|
UBS Group
Zurich,
Switzerland
|
$17.7M
|
+$12.2M
|
+392,089
|
+190%
|
|
|
31
|
EcoR1 Capital
San Francisco,
California
|
$16.5M
|
–
|
–
|
–
|
|
|
32
|
|
$15.5M
|
-$21.4M
|
-688,080
|
-57%
|
|
|
33
|
Frazier Life Sciences Management
Palo Alto,
California
|
$15.5M
|
+$16.4M
|
+525,000
|
New
|
|
|
34
|
Marshall Wace
London,
United Kingdom
|
$13.4M
|
+$9.1M
|
+292,332
|
+179%
|
|
|
35
|
|
$13M
|
-$291K
|
-9,342
|
-2%
|
|
|
36
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$13M
|
+$2.44M
|
+78,389
|
+22%
|
|
|
37
|
TD Asset Management
Toronto,
Ontario, Canada
|
$12.8M
|
+$560K
|
+17,970
|
+4%
|
|
|
38
|
Nuveen
Charlotte,
North Carolina
|
$12.7M
|
+$2.45M
|
+78,713
|
+22%
|
|
|
39
|
Alethea Capital Management
Mercer Island,
Washington
|
$12.4M
|
+$26.6K
|
+853
|
+0.2%
|
|
|
40
|
Silverarc Capital Management
Boston,
Massachusetts
|
$12.1M
|
-$4.12M
|
-132,339
|
-24%
|
|
|
41
|
Cormorant Asset Management
Boston,
Massachusetts
|
$11.8M
|
-$20.2M
|
-650,000
|
-62%
|
|
|
42
|
Finepoint Capital
Boston,
Massachusetts
|
$11.2M
|
-$330K
|
-10,600
|
-3%
|
|
|
43
|
Sofinnova Investments
Menlo Park,
California
|
$11.2M
|
+$11.4M
|
+366,142
|
+2,655%
|
|
|
44
|
|
$11.1M
|
+$5.83M
|
+187,325
|
+99%
|
|
|
45
|
Eventide Asset Management
Boston,
Massachusetts
|
$11.1M
|
–
|
–
|
–
|
|
|
46
|
Bank of New York Mellon
New York
|
$10.8M
|
+$111K
|
+3,577
|
+1%
|
|
|
47
|
|
$10.6M
|
+$789K
|
+25,329
|
+8%
|
|
|
48
|
Logos Global Management
San Francisco,
California
|
$10.3M
|
+$10.9M
|
+350,000
|
New
|
|
|
49
|
VOYA Investment Management
Atlanta,
Georgia
|
$9.81M
|
-$436K
|
-14,006
|
-4%
|
|
|
50
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$9.74M
|
+$9.41M
|
+302,028
|
+1,081%
|
|
